Bradley J. Monk
AuthID: R-00K-269
1
TITLE: Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley J Monk; Helen MacKay; Alessandro D Santin; David Scott Miller ; Richard G Moore; Sally Baron Hay; Isabelle Ray Coquard; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Steven Bird; Robert Orlowski; Jodi McKenzie; Chinyere Okpara; Gianmaria Barresi; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 16
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley J Monk; Helen MacKay; Alessandro D Santin; David Scott Miller ; Richard G Moore; Sally Baron Hay; Isabelle Ray Coquard; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Steven Bird; Robert Orlowski; Jodi McKenzie; Chinyere Okpara; Gianmaria Barresi; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 16
2
TITLE: O018/#482 Updated safety of lenvatinib + pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley Monk; Helen Mackay; Alessandro Santin; David Scott Miller ; Richard Moore; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva Guerra Alia; Ulus Sanli; Ran Xie; Melissa Zale; Jodi Mckenzie; Gianmaria Barresi; Domenica Lorusso;
PUBLISHED: 2022, SOURCE: Focused Plenary Abstracts
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley Monk; Helen Mackay; Alessandro Santin; David Scott Miller ; Richard Moore; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva Guerra Alia; Ulus Sanli; Ran Xie; Melissa Zale; Jodi Mckenzie; Gianmaria Barresi; Domenica Lorusso;
PUBLISHED: 2022, SOURCE: Focused Plenary Abstracts
INDEXED IN: 
CrossRef
CrossRef3
TITLE: Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
AUTHORS: Kathleen N Moore; Angeles Alvarez Secord; Melissa A Geller; David Scott Miller ; Noelle Cloven; Gini F Fleming; Andrea E Wahner Hendrickson; Masoud Azodi; Paul DiSilvestro; Amit M Oza; Mihaela Cristea; Jonathan S Berek; John K Chan; Bobbie J Rimel; Daniela E Matei; Yong Li; Kaiming Sun; Katarina Luptakova; Ursula A Matulonis; Bradley J Monk;
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 5
AUTHORS: Kathleen N Moore; Angeles Alvarez Secord; Melissa A Geller; David Scott Miller ; Noelle Cloven; Gini F Fleming; Andrea E Wahner Hendrickson; Masoud Azodi; Paul DiSilvestro; Amit M Oza; Mihaela Cristea; Jonathan S Berek; John K Chan; Bobbie J Rimel; Daniela E Matei; Yong Li; Kaiming Sun; Katarina Luptakova; Ursula A Matulonis; Bradley J Monk;
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 5
4
TITLE: Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
AUTHORS: Ignace Vergote; Giovanni Scambia; David M O'Malley; Ben Van Calster; Sang Yoon Park; Josep M del Campo; Werner Meier; Aristotelis Bamias; Nicoletta Colombo; Robert M Wenham; Al Covens; Christian Marth; Mansoor Raza Mirza; Judith R Kroep; Haijun Ma; Cheryl A Pickett; Bradley J Monk; Sang Yoon Park; Yong Sang Song; Yulia Makarova; ...More
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 6
AUTHORS: Ignace Vergote; Giovanni Scambia; David M O'Malley; Ben Van Calster; Sang Yoon Park; Josep M del Campo; Werner Meier; Aristotelis Bamias; Nicoletta Colombo; Robert M Wenham; Al Covens; Christian Marth; Mansoor Raza Mirza; Judith R Kroep; Haijun Ma; Cheryl A Pickett; Bradley J Monk; Sang Yoon Park; Yong Sang Song; Yulia Makarova; ...More
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 6
5
TITLE: Reply to W.A.A. Tjalma and J.S. Grossman
AUTHORS: Bradley J Monk; David Scott Miller ; Krishnansu S Tewari;
PUBLISHED: 2015, SOURCE: Journal of Clinical Oncology, VOLUME: 33, ISSUE: 8
AUTHORS: Bradley J Monk; David Scott Miller ; Krishnansu S Tewari;
PUBLISHED: 2015, SOURCE: Journal of Clinical Oncology, VOLUME: 33, ISSUE: 8
6
TITLE: Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study Full Text
AUTHORS: Harry J Long; Bradley J Monk; Helen Q Huang; Edward C Grendys; Scott S McMeekin; Joel Sorosky; David Scott Miller ; Lynne A Eaton; James V Fiorica;
PUBLISHED: 2006, SOURCE: Gynecologic Oncology, VOLUME: 100, ISSUE: 3
AUTHORS: Harry J Long; Bradley J Monk; Helen Q Huang; Edward C Grendys; Scott S McMeekin; Joel Sorosky; David Scott Miller ; Lynne A Eaton; James V Fiorica;
PUBLISHED: 2006, SOURCE: Gynecologic Oncology, VOLUME: 100, ISSUE: 3
